A Phase 2, single-arm, open-label study to evaluate the safety and efficacy of MGTA-456 in patients with sickle cell disease (SCD) undergoing hematopoietic stem cell transplantation (HSCT)

  • Smith, Angela R (PI)

Project: Research project

Project Details

Description

A Phase 2, single-arm, open-label study to evaluate the safety and efficacy of MGTA-456 in patients with sickle cell disease (SCD) undergoing hematopoietic stem cell transplantation (HSCT)
StatusFinished
Effective start/end date1/1/20 → 12/31/20

Funding

  • MEDPACE, INC.
  • MAGENTA THERAPEUTICS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint